Skip to main content

Hemophilia A News (Page 2)

FDA Approves Nuwiq (Antihemophilic Factor [Recombinant]) for Hemophilia A

HOBOKEN, N.J. September 15th, 2015: Octapharma USA today announced the U.S. Food and Drug Administration (FDA) has approved Nuwiq, Antihemophilic Factor (Recombinant), an intravenous therapy for...

FDA Approves Obizur [Antihemophilic Factor (Recombinant)] for Acquired Hemophilia A

DEERFIELD, Ill., October 24, 2014 - Baxter International Inc. today announced that the United States Food and Drug Administration (FDA) has approved Obizur [Antihemophilic Factor (Recombinant),...

FDA Approves Eloctate - first Antihemophilic Factor, Fc Fusion Protein for Patients with Hemophilia A

June 6, 2014 – The U.S. Food and Drug Administration today approved Eloctate, Antihemophilic Factor (Recombinant), Fc fusion protein, for use in adults and children who have Hemophilia A. Eloctate...

NovoEight (turoctocog alfa) Receives Approval from the FDA

Bagsværd, Denmark, 16 October 2013 – Today, Novo Nordisk announced that the U.S. Food and Drug Administration (FDA) has approved its Biologics License Application (BLA) for recombinant coagulation fa...

Ask a question

To post your own question to this support group, sign in or create an account.